Pomanda estimates the enterprise value of ETHYPHARM UK LIMITED at £6.6m based on a Turnover of £10.8m and 0.61x industry multiple (adjusted for size and gross margin).
ethypharm uk limitedEstimated Valuation
£2.8m
Pomanda estimates the enterprise value of ETHYPHARM UK LIMITED at £2.8m based on an EBITDA of £457k and a 6.17x industry multiple (adjusted for size and gross margin).
ethypharm uk limitedEstimated Valuation
£24m
Pomanda estimates the enterprise value of ETHYPHARM UK LIMITED at £24m based on Net Assets of £12.5m and 1.92x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Ethypharm Uk LimitedOverview
Ethypharm Uk Limited is a live company located in essex, RM3 8UG with a Companies House number of 08565401. It operates in the wholesale of pharmaceutical goods sector, SIC Code 46460. Founded in June 2013, it's largest shareholder is
dallas burston ashbourne holdings ltd
with a 100% stake. Ethypharm Uk Limited is a established,
mid sized company, Pomanda has estimated its turnover at
£10.8m with
declining
growth in recent years.
Pomanda's financial health check has awarded Ethypharm Uk Limited a 3.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
Health Rating3.5out of 5
4 Strong
3 Regular
4 Weak
Size
annual sales of £10.8m, make it smaller than the average company (£24.4m)
£10.8m - Ethypharm Uk Limited
£24.4m - Industry AVG
Growth
3 year (CAGR) sales growth of -41%, show it is growing at a slower rate (5.3%)
-41% - Ethypharm Uk Limited
5.3% - Industry AVG
Production
with a gross margin of 31.8%, this company has a comparable cost of product (29.5%)
31.8% - Ethypharm Uk Limited
29.5% - Industry AVG
Profitability
an operating margin of 4.2% make it as profitable than the average company (4.1%)
4.2% - Ethypharm Uk Limited
4.1% - Industry AVG
Employees
with 88 employees, this is above the industry average (36)
88 - Ethypharm Uk Limited
36 - Industry AVG
Pay Structure
on an average salary of £72.9k, the company has an equivalent pay structure (£81.2k)
£72.9k - Ethypharm Uk Limited
£81.2k - Industry AVG
Efficiency
resulting in sales per employee of £123.1k, this is less efficient (£656k)
£123.1k - Ethypharm Uk Limited
£656k - Industry AVG
Debtor Days
it gets paid by customers after 0 days, this is earlier than average (57 days)
0 days - Ethypharm Uk Limited
57 days - Industry AVG
Creditor Days
its suppliers are paid after 44 days, this is slower than average (29 days)
44 days - Ethypharm Uk Limited
29 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Ethypharm Uk Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 0 weeks, this is less cash available to meet short term requirements (11 weeks)
0 weeks - Ethypharm Uk Limited
11 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 36.8%, this is a lower level of debt than the average (54.4%)
36.8% - Ethypharm Uk Limited
54.4% - Industry AVG
ETHYPHARM UK LIMITED financials
EXPORT
Ethypharm Uk Limited's latest turnover from December 2023 is £10.8 million and the company has net assets of £12.5 million. According to their latest financial statements, Ethypharm Uk Limited has 88 employees and maintains cash reserves of £76 thousand as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Mar 2015
Mar 2014
Turnover
10,829,000
41,777,000
54,387,000
52,808,000
47,719,000
45,235,000
32,969,000
28,828,196
21,556,473
26,991,452
Other Income Or Grants
Cost Of Sales
7,382,000
37,158,000
48,496,000
47,391,000
43,417,000
37,085,000
27,939,000
24,350,385
17,810,756
20,464,318
Gross Profit
3,447,000
4,619,000
5,891,000
5,417,000
4,302,000
8,150,000
5,030,000
4,477,811
3,745,717
6,527,134
Admin Expenses
2,990,000
3,331,000
3,719,000
3,322,000
3,467,000
7,580,000
3,146,000
3,323,869
2,544,996
4,127,169
Operating Profit
457,000
1,288,000
2,172,000
2,095,000
835,000
570,000
1,884,000
1,153,942
1,200,721
2,399,965
Interest Payable
15,000
426
18,188
20,881
Interest Receivable
Pre-Tax Profit
457,000
1,288,000
2,172,000
2,095,000
835,000
570,000
1,869,000
1,153,516
1,182,533
2,379,084
Tax
-150,000
-356,000
-231,500
-248,506
-518,298
Profit After Tax
457,000
1,288,000
2,172,000
2,095,000
685,000
570,000
1,513,000
922,016
934,027
1,860,786
Dividends Paid
Retained Profit
457,000
1,288,000
2,172,000
2,095,000
685,000
570,000
1,513,000
922,016
934,027
1,860,786
Employee Costs
6,415,000
6,206,000
6,042,000
6,101,000
6,274,000
4,552,000
1,233,000
1,064,505
118,159
184,774
Number Of Employees
88
86
89
95
93
98
17
15
4
5
EBITDA*
457,000
1,288,000
2,172,000
2,095,000
835,000
570,000
1,884,000
1,153,942
1,200,721
2,399,965
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Mar 2015
Mar 2014
Tangible Assets
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
Total Fixed Assets
Stock & work in progress
3,728,000
3,127,759
Trade Debtors
16,000
6,012,000
11,585,000
9,677,000
11,805,000
17,897,000
7,382,000
8,898,474
7,423,641
6,819,484
Group Debtors
18,483,000
15,711,000
6,436,000
9,912,000
8,514,000
8,748,000
6,329,000
2,901,541
1,178,387
Misc Debtors
1,196,000
60,000
152,000
62,000
140,000
303,000
1,003,000
121,651
273,720
4,939,309
Cash
76,000
9,660,000
11,553,000
17,930,000
4,111,000
7,446,000
6,034,000
749,286
31,945
214,470
misc current assets
total current assets
19,771,000
31,443,000
29,726,000
37,581,000
24,570,000
34,394,000
24,476,000
15,798,711
8,907,693
11,973,263
total assets
19,771,000
31,443,000
29,726,000
37,581,000
24,570,000
34,394,000
24,476,000
15,798,711
8,907,693
11,973,263
Bank overdraft
Bank loan
700,000
Trade Creditors
899,000
1,221,000
784,000
29,000
428,000
5,619,000
670,000
630,280
708,674
843,196
Group/Directors Accounts
4,863,000
3,380,000
3,112,000
14,868,000
8,604,000
13,384,000
14,705,000
8,268,910
3,511,043
4,640,787
other short term finances
hp & lease commitments
other current liabilities
1,511,000
14,801,000
15,077,000
14,103,000
9,052,000
9,590,000
3,870,000
3,182,592
1,893,063
3,928,394
total current liabilities
7,273,000
19,402,000
18,973,000
29,000,000
18,084,000
28,593,000
19,245,000
12,081,782
6,112,780
10,112,377
loans
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
total long term liabilities
total liabilities
7,273,000
19,402,000
18,973,000
29,000,000
18,084,000
28,593,000
19,245,000
12,081,782
6,112,780
10,112,377
net assets
12,498,000
12,041,000
10,753,000
8,581,000
6,486,000
5,801,000
5,231,000
3,716,929
2,794,913
1,860,886
total shareholders funds
12,498,000
12,041,000
10,753,000
8,581,000
6,486,000
5,801,000
5,231,000
3,716,929
2,794,913
1,860,886
Dec 2023
Dec 2022
Dec 2021
Dec 2020
Dec 2019
Dec 2018
Dec 2017
Dec 2016
Dec 2015
Mar 2015
Mar 2014
Operating Activities
Operating Profit
457,000
1,288,000
2,172,000
2,095,000
835,000
570,000
1,884,000
1,153,942
1,200,721
2,399,965
Depreciation
Amortisation
Tax
-150,000
-356,000
-231,500
-248,506
-518,298
Stock
-3,728,000
600,241
3,127,759
Debtors
-2,088,000
3,610,000
-1,478,000
-808,000
-6,489,000
12,234,000
2,792,334
3,045,918
8,875,748
11,758,793
Creditors
-322,000
437,000
755,000
-399,000
-5,191,000
4,949,000
39,720
-78,394
708,674
843,196
Accruals and Deferred Income
-13,290,000
-276,000
974,000
5,051,000
-538,000
5,720,000
687,408
1,289,529
1,893,063
3,928,394
Deferred Taxes & Provisions
Cash flow from operations
-11,067,000
-2,161,000
5,379,000
7,555,000
1,445,000
2,733,000
-1,137,447
-4,040,100
-5,321,796
-5,105,536
Investing Activities
capital expenditure
Change in Investments
cash flow from investments
Financing Activities
Bank loans
700,000
Group/Directors Accounts
1,483,000
268,000
-11,756,000
6,264,000
-4,780,000
-1,321,000
6,436,090
4,757,867
3,511,043
4,640,787
Other Short Term Loans
Long term loans
Hire Purchase and Lease Commitments
other long term liabilities
share issue
1,071
1,860,886
100
interest
-15,000
-426
-18,188
-20,881
cash flow from financing
1,483,000
268,000
-11,756,000
6,264,000
-4,780,000
-1,321,000
6,422,161
4,757,441
5,353,741
5,320,006
cash and cash equivalents
cash
-9,584,000
-1,893,000
-6,377,000
13,819,000
-3,335,000
1,412,000
5,284,714
717,341
31,945
214,470
overdraft
change in cash
-9,584,000
-1,893,000
-6,377,000
13,819,000
-3,335,000
1,412,000
5,284,714
717,341
31,945
214,470
ethypharm uk limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for ethypharm uk limited. Get real-time insights into ethypharm uk limited's credit score, group structure and payment trends.
Perform a competitor analysis for ethypharm uk limited by selecting its closest rivals, whether from the WHOLESALE AND RETAIL TRADE; REPAIR OF MOTOR VEHICLES AND MOTORCYCLES sector, other mid companies, companies in RM3 area or any other competitors across 12 key performance metrics.
The sole shareholder of Ethypharm Uk Limited is Dallas Burston Ashbourne Holdings Ltd.
dallas burston ashbourne holdings ltd
100%
ethypharm uk limited directors
Ethypharm Uk Limited currently has 4 directors.
The longest serving directors include
Mr Bruno De Ultra De Sousa Barcelos (Jan 2023) and
Mr Xavier Lasserre (Jun 2023).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to ethypharm uk limited. Currently there are 0 open charges and 2 have been satisfied in the past.
ethypharm uk limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for ETHYPHARM UK LIMITED. This can take several minutes, an email will notify you when this has completed.
ethypharm uk limitedCompanies House Filings - See Documents
